Add to ORKGnone17noneFanti S.; Yu JQ.; Castellucci P.; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuang HM.; Cavo M.; Baccarani M.; Franchi R.; Salizzoni E.; Canini R.; Monetti N.; Alavi A.Fanti S.; Yu JQ.; Castellucci P.; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuang HM.; Cavo M.; Baccarani M.; Franchi R.; Salizzoni E.; Canini R.; Monetti N.; Alavi A
New imaging techniques have been introduced to assess the ex-tent and severity of disease in multipl...
New imaging techniques have been introduced to assess the extent and severity of disease in multiple...
FDG PET/CT is able to detect active disease in patients with multiple myeloma (MM) and can be helpfu...
none14noneFanti S.; Yu JQ; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuangh...
National Special Fund for the Development of Major Research Equipment and Instrument [2011YQ030114...
International audienceMultiple myeloma (MM) is a hematological neoplasm characterized by the clonal ...
none2noMultiple myeloma is a plasma cell dyscrasia producing bone lytic lesions. In recent years, a ...
none3noBone disease is the most frequent feature of multiple myeloma (MM) and represents a marker of...
Abstract Background Despite the significant upgrading in recent years of the role of 18F-FDG PET/CT ...
none28siThe International Myeloma Working Group consensus aimed to provide recommendations for the o...
none18noneZamagni E; Nanni C; Patriarca F; Englaro E; Castellucci P; Geatti O; Tosi P; Tacchetti P; ...
International audienceSerum markers and bone marrow examination are commonly used for monitoring the...
International audienceMultiple myeloma is a malignant B-cell neoplasm that involves the skeleton in ...
Multiple myeloma (MM) is a plasma cell malignancy and is characterized by the presence of lytic bone...
none10noneC. Nanni; V. Ambrosini; E. Zamagni; M. Farsad; P. Castellucci; M. Sansovini; D. Rubello; G...
New imaging techniques have been introduced to assess the ex-tent and severity of disease in multipl...
New imaging techniques have been introduced to assess the extent and severity of disease in multiple...
FDG PET/CT is able to detect active disease in patients with multiple myeloma (MM) and can be helpfu...
none14noneFanti S.; Yu JQ; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuangh...
National Special Fund for the Development of Major Research Equipment and Instrument [2011YQ030114...
International audienceMultiple myeloma (MM) is a hematological neoplasm characterized by the clonal ...
none2noMultiple myeloma is a plasma cell dyscrasia producing bone lytic lesions. In recent years, a ...
none3noBone disease is the most frequent feature of multiple myeloma (MM) and represents a marker of...
Abstract Background Despite the significant upgrading in recent years of the role of 18F-FDG PET/CT ...
none28siThe International Myeloma Working Group consensus aimed to provide recommendations for the o...
none18noneZamagni E; Nanni C; Patriarca F; Englaro E; Castellucci P; Geatti O; Tosi P; Tacchetti P; ...
International audienceSerum markers and bone marrow examination are commonly used for monitoring the...
International audienceMultiple myeloma is a malignant B-cell neoplasm that involves the skeleton in ...
Multiple myeloma (MM) is a plasma cell malignancy and is characterized by the presence of lytic bone...
none10noneC. Nanni; V. Ambrosini; E. Zamagni; M. Farsad; P. Castellucci; M. Sansovini; D. Rubello; G...
New imaging techniques have been introduced to assess the ex-tent and severity of disease in multipl...
New imaging techniques have been introduced to assess the extent and severity of disease in multiple...
FDG PET/CT is able to detect active disease in patients with multiple myeloma (MM) and can be helpfu...